Building confidence at the edge through embedded trust anchors

Tern plc

As digital infrastructure expands across sectors such as healthcare, energy, and manufacturing, the cost of weak or default identities is no longer theoretical. Every unverified connection introduces potential disruption, regulatory risk, and in the most critical environments, threats to safety itself.

Device Authority has placed this foundational challenge at the centre of its Zero Trust strategy. Through its KeyScaler® platform, the company has redefined how identity and policy can be embedded at the edge, directly within the manufacturing and onboarding stages of connected devices. By automating the creation of strong, unique identities tied to secure hardware or generated dynamically where hardware roots of trust do not exist, the system removes the manual processes that often lead to configuration errors and scalability issues. This enables manufacturers and operators to secure fleets of devices from the instant they connect, without human intervention or bottlenecks.

When partnered with Olympus, KeyScaler allows trust anchors to feed directly into enterprise identity and access management systems, ensuring that every device remains under continuous policy governance. Context, behaviour, and health signals can trigger automated responses, from restricted access to complete revocation, ensuring that any anomaly is addressed instantly and proportionately.

Importantly, Device Authority’s approach also acknowledges industrial reality. Many enterprises must work with extensive brownfield environments where legacy assets lack the modern security hardware of new devices. For these cases, KeyScaler’s Dynamic Device Key Generation and Trust on First Use models create strong, software-based identities that can later be reinforced through re-enrolment or attestation.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Pharma faces a strategic turning point in AI adoption

AI in pharma is moving from operational support to strategic driver as companies prioritise messaging that delivers measurable prescriber impact.

Tern Plc updates position in Talking Medicines with new convertible loan notes

Tern Plc has received about £230,000 in new unsecured convertible loan notes from Talking Medicines after cancelling around £180,000 of short term loans provided over 2024 and 2025.

The real problem holding back connected vehicle programmes

Vehicle identity is fast becoming a core infrastructure challenge, and a new bottleneck for OEMs aiming to scale software-defined platforms.

Talking Medicines is building the AI layer beneath pharma marketing

Talking Medicines is shifting pharma marketing from content creation to data control, building the layer AI tools rely on to deliver credible, measurable clinical messaging.

A shift in how IoT is secured by default

KeyScaler 2025 transforms IoT security by automating trust across every device’s lifecycle, from onboarding to decommissioning, turning scalable connectivity and compliance into a built-in feature.

Turning employee sentiment into hard operational data

Workforce wellbeing is becoming a source of operational data, and the companies acting early are already reducing risk.

Search

Search